Infection Control Measures in Dialysis Facilities after COVID-19: Disparities in Adoption and Impact on Hospitalization and Mortality

COVID-19 后透析设施的感染控制措施:采用差异以及对住院和死亡率的影响

基本信息

  • 批准号:
    10193135
  • 负责人:
  • 金额:
    $ 47.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-01-01 至 2022-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY The COVID-19 pandemic threatens the health of patients with kidney failure because end-stage kidney disease (ESKD) is a risk factor for COVID-19 related death. Most patients with kidney failure undergo hemodialysis treatment in an outpatient dialysis facility three times a week alongside other patients. This can result in unavoidable patient clustering and an increased risk of viral transmission. Further, patients with kidney failure often have multiple comorbidities, high baseline rates of mortality, and are more likely to be black or Hispanic, racial/ethnic minority groups that have been disproportionately impacted by the pandemic. High hospitalization rates for ESKD patients also demands a health care system that allows seamless care coordination between the outpatient dialysis facilities and hospitals. In order to mitigate patients' risk of contracting COVID-19, facilities could implement several precautionary measures, including reducing the duration of each hemodialysis treatment session, assigning patients to separate facilities or shifts that specifically accommodate COVID-19 patients, establishing additional “isolation” stations within a facility, offering training and support for patients receiving home dialysis, and providing care to nursing home residents in the nursing home as opposed to an outpatient dialysis facility. Some dialysis facilities have reported implementing these strategies, but systematic national data about their adoption and association with meaningful patient outcomes are not known. Using data from the universe of all outpatient dialysis facilities and a census of patients with kidney failure undergoing dialysis for the period 2018-2022, this project has three aims. First, we estimate the extent to which COVID-19 spurred the facility-level adoption of infection-control practices, and to examine the heterogeneity in adoption across facilities. Our working hypothesis is that facilities affiliated with LDOs, those located in disadvantaged neighborhoods, and those in counties with high infection rates will be more likely to adopt protective measures in response to the threat of COVID-19. Second, we investigate the effectiveness of facility-level infection-control responses on COVID-19 related- and all-cause hospitalization and mortality. Our working hypothesis is that infection control measures resulted in a reduction of infection- related hospitalizations and mortality, but non-COVID-19 and overall hospitalization and mortality rates increased. Third, we estimate the extent to which hemodialysis sessions were impacted for dialysis patients admitted to hospitals in high-COVID-19 counties. Our working hypothesis is that dialysis patients admitted to hospitals in counties with high COVID-19 infection rates or COVID-19 “hotspots” experience greater reductions in dialysis sessions. Overall, our study will have a positive impact since dissemination of information about responses found effective will allow other facilities to adopt them, and reduce COVID-19 transmission in this vulnerable patient population.
项目摘要 COVID-19大流行威胁着肾衰竭患者的健康,因为末期肾脏 疾病(ESKD)是大多数肾衰竭患者的危险因素。 每周与其他患者一起进行门诊透析设施中的血液透析治疗 可能导致不可避免的患者聚类和进一步的病毒传播风险 随着肾脏衰竭通常具有多裂合并症,死亡率高的基准率,并且更可能也很可能 是黑人或西班牙裔,种族/族裔少数群体,受到了受到影响的影响 ESKD患者的大流行还需要 无缝的护理协调在乘场设施和医院。 为了减轻患者患者的Covid-19风险,设施可以实施几种预防措施 措施,包括减少每个血液透析治疗课程的持续时间,将患者分配给 单独的设施或班次,专门针对Accomode Covid-19患者,建立了其他 设施内的“隔离”站,为接受家庭透析和透析的患者提供培训和支持。 为疗养院的养老院居民提供护理,以便在门诊透析设施中提供护理。 一些透析设施报告了实施这些策略,但有关系统的国家数据 他们的采用和与有意义的patcomes的关系尚不清楚。 使用所有门诊透析设施的宇宙数据和肾脏毛毛病患者的普查 在2018 - 2022年期间,透析有三个目标。 19ciD-19刺激了设施级的采用感染控制实践,并检查了您 我们的工作假设是跨设施的异质性。 在处境不利的社区中 我们可能会采取保护性措施,以响应于19的螺纹 设施级感染控制对19相关19相关19和全因医院的有效性 和死亡率。 相关的住院和砂浆,但非卵路19,总体住院和死亡率 增加。 在19个县接受了透析患者的糖尿病。 在199年感染率高或共同的“热点”县的山脉中,经历更大的体验 透析疗法的减少。 有关发现有效响应的信息将使其他设施可以采用它们,并减少Covid-19 在这个脆弱的患者人群中传播。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMAL N. TRIVEDI其他文献

AMAL N. TRIVEDI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMAL N. TRIVEDI', 18)}}的其他基金

Impact of COVID-era Disrupted Care on Disparities in Outcomes among Veterans with Kidney Failure
新冠病毒时代护理中断对肾功能衰竭退伍军人结果差异的影响
  • 批准号:
    10755601
  • 财政年份:
    2022
  • 资助金额:
    $ 47.95万
  • 项目类别:
Impact of COVID-era Disrupted Care on Disparities in Outcomes among Veterans with Kidney Failure
新冠病毒时代护理中断对肾功能衰竭退伍军人结果差异的影响
  • 批准号:
    10424969
  • 财政年份:
    2022
  • 资助金额:
    $ 47.95万
  • 项目类别:
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease
扩大医疗保险优惠覆盖范围对终末期肾病患者的影响
  • 批准号:
    10435533
  • 财政年份:
    2021
  • 资助金额:
    $ 47.95万
  • 项目类别:
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease
扩大医疗保险优惠覆盖范围对终末期肾病患者的影响
  • 批准号:
    10275943
  • 财政年份:
    2021
  • 资助金额:
    $ 47.95万
  • 项目类别:
Effects of Expanding Medicare Advantage Enrollment toPersons with End-stage Renal Disease
扩大医疗保险优惠覆盖范围对终末期肾病患者的影响
  • 批准号:
    10609923
  • 财政年份:
    2021
  • 资助金额:
    $ 47.95万
  • 项目类别:
Infection Control Measures in Dialysis Facilities after COVID-19: Disparities in Adoption and Impact on Hospitalization and Mortality
COVID-19 后透析设施的感染控制措施:采用差异以及对住院和死亡率的影响
  • 批准号:
    10321302
  • 财政年份:
    2021
  • 资助金额:
    $ 47.95万
  • 项目类别:
Impact of VA Disability and Health Benefits on Long-Term Diabetes Outcomes among Vietnam-Era Veterans
退伍军人事务部残疾和健康福利对越战时期退伍军人长期糖尿病结局的影响
  • 批准号:
    10051323
  • 财政年份:
    2018
  • 资助金额:
    $ 47.95万
  • 项目类别:
Medicaid Expansion, Coverage Loss, and Disparities in Kidney Health in the COVID-19 Era
COVID-19 时代的医疗补助范围扩大、覆盖范围缩小以及肾脏健康方面的差异
  • 批准号:
    10447753
  • 财政年份:
    2017
  • 资助金额:
    $ 47.95万
  • 项目类别:
Risk-Adjusting Hospital Outcomes for Veteran's Socioeconomic Status
根据退伍军人的社会经济地位调整医院结果的风险
  • 批准号:
    9188841
  • 财政年份:
    2017
  • 资助金额:
    $ 47.95万
  • 项目类别:
Medicaid Expansion, Coverage Loss, and Disparities in Kidney Health in the COVID-19 Era
COVID-19 时代的医疗补助范围扩大、覆盖范围缩小以及肾脏健康方面的差异
  • 批准号:
    10208073
  • 财政年份:
    2017
  • 资助金额:
    $ 47.95万
  • 项目类别:

相似国自然基金

小曲率半径叠交盾构隧道施工软土地层三维变形特性及控制措施研究
  • 批准号:
    42307260
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
无对照的合成控制法评价群体干预措施效果的因果推断方法研究
  • 批准号:
    82304243
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
极端气候对密云水库上游流域非点源氮磷污染及其控制措施的影响机制研究
  • 批准号:
    42307087
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
深基坑开挖对紧邻运营隧道影响机理与控制措施研究
  • 批准号:
    52238009
  • 批准年份:
    2022
  • 资助金额:
    270 万元
  • 项目类别:
    重点项目
风电基地交流外送系统次/超同步动态稳定性量化分析方法与控制措施的研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
  • 批准号:
    10678074
  • 财政年份:
    2023
  • 资助金额:
    $ 47.95万
  • 项目类别:
Evaluating the Effects of Animal Therapy on Anxiety in Pediatric Dental Patients
评估动物疗法对小儿牙科患者焦虑的影响
  • 批准号:
    10649010
  • 财政年份:
    2023
  • 资助金额:
    $ 47.95万
  • 项目类别:
Achieving Sustained Control of Inflammation to Prevent Post-Traumatic Osteoarthritis (PTOA)
实现炎症的持续控制以预防创伤后骨关节炎 (PTOA)
  • 批准号:
    10641225
  • 财政年份:
    2023
  • 资助金额:
    $ 47.95万
  • 项目类别:
The role of the gut microbiome in susceptibility to Mycobacterium tuberculosis
肠道微生物组在结核分枝杆菌易感性中的作用
  • 批准号:
    10647554
  • 财政年份:
    2023
  • 资助金额:
    $ 47.95万
  • 项目类别:
Arthroscopic-assisted tibial plateau fixation (AATPF) vs. Open reduction internal fixation (ORIF): A multicenter randomized controlled trial
关节镜辅助胫骨平台固定术 (AATPF) 与切开复位内固定术 (ORIF):一项多中心随机对照试验
  • 批准号:
    10723527
  • 财政年份:
    2023
  • 资助金额:
    $ 47.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了